Several studies on gene expression have shown that breast cancer can beclassified into at least five specific subtypes: luminal A, luminal B, human epidermal receptortype 2 (HER2)-overexpressing, basal-like, and normal breast-like.2,3 Clinical outcomes have beenshown to depend on differences in tumor gene expression patterns.3 This evidence concerns the gene ERBB2 and breast cancer.